ClinicalTrials.gov
public full text
Public Domain
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
The clinical syndrome of PSP responds poorly to all available forms of therapy used in Parkinson's Disease (PD). Currently, no effective treatment exists. Coenzyme Q10 in high doses has been shown to be a beneficial therapy in PD and might possibly be a beneficial therapy for PSP. This study will compare the efficacy, safety and tolerability of Coenzyme Q10 versus placebo in patients with atypical parkinsonian syndrome, progressive supranuclear palsy (PSP).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy#1246328
- Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood#884713
- Parkinson's Disease Treatment With Coenzyme Q10#911861
- Integrating AI in Postural Rehabilitation for Parkinson's Disease#1340344
- REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study#808100
Record · ID 1372333
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive